Vascular Endothelial Growth Factor (VEGF) Trap

Status: Completed

ClinicalTrials.gov Identifier: NCT00320788

VGFT-OD-0508: This study examines the effect of intravitreally administered VEGF Trap in patients with wet AMD. The purpose of this trial is to assess the ocular and systemic safety and tolerability of repeated intravitreal doses of VEGF Trap in patients with subfoveal choroidal neovascularization (CNV) due to AMD.

Condition: Macular Degeneration

Study Type: Interventional

Duration: 28 months

Eligibility:

  • Ages: 50 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.